Hodgkinʼs Disease in Adults

Abstract

Editor From the *Clinical Services Program, Program Resources, Inc./ DynCorp, and †Biological Response Modifiers Program, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland. The contents of this publication do not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government. By acceptance of this article, the publisher or recipient acknowledges the right of the U.S. government to retain a nonexclusive, royalty-free license in and to any copyright covering the article. Editor's note: This is part two of a two-part article. The first part was published in the August 1993 issue of Investigative Radiology. Reprint requests: Walter J. Urba, MD, PhD, Clinical Services Program, Program Resources, Inc/DynCorp, Biological Response Modifiers Program, National Cancer Institute, Frederick Cancer Research and Development Center, P.O. Box B, Frederick, MD 21702-1201. Received and accepted for publication, after revision, February 23, 1993.